MetLife Investment Management’s Fortune Brands Innovations FBIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.15M | Sell |
57,380
-1,732
| -3% | -$69.4K | 0.01% | 888 |
|
|
2026
Q1 | $2.3M | Buy |
59,112
+397
| +0.7% | +$20.6K | 0.01% | 987 |
|
|
2025
Q4 | $2.94M | Sell |
58,715
-2,998
| -5% | -$150K | 0.01% | 877 |
|
|
2025
Q3 | $3.29M | Sell |
61,713
-3,055
| -5% | -$172K | 0.02% | 842 |
|
|
2025
Q2 | $3.33M | Sell |
64,768
-4,194
| -6% | -$219K | 0.02% | 761 |
|
|
2025
Q1 | $4.2M | Sell |
68,962
-1,045
| -1% | -$70.2K | 0.02% | 704 |
|
|
2024
Q4 | $4.78M | Buy |
70,007
+5,879
| +9% | +$471K | 0.03% | 582 |
|
|
2024
Q3 | $5.74M | Sell |
64,128
-1,730
| -3% | -$133K | 0.03% | 453 |
|
|
2024
Q2 | $4.28M | Sell |
65,858
-3,421
| -5% | -$247K | 0.03% | 583 |
|
|
2024
Q1 | $5.87M | Sell |
69,279
-1,827
| -3% | -$145K | 0.04% | 411 |
|
|
2023
Q4 | $5.41M | Sell |
71,106
-1,604
| -2% | -$106K | 0.04% | 413 |
|
|
2023
Q3 | $4.52M | Sell |
72,710
-3,220
| -4% | -$221K | 0.04% | 465 |
|
|
2023
Q2 | $5.46M | Sell |
75,930
-4,458
| -6% | -$284K | 0.04% | 397 |
|
|
2023
Q1 | $4.72M | Sell |
80,388
-2,144
| -3% | -$131K | 0.03% | 485 |
|
|
2022
Q4 | $4.71M | Buy |
82,532
+40,220
| +95% | +$2.11M | 0.04% | 469 |
|
|
2022
Q3 | $1.94M | Sell |
42,312
-1,065
| -2% | -$57.8K | 0.02% | 892 |
|
|
2022
Q2 | $2.22M | Sell |
43,377
-1,626
| -4% | -$95.3K | 0.02% | 860 |
|
|
2022
Q1 | $2.86M | Buy |
45,003
+9,917
| +28% | +$763K | 0.02% | 841 |
|
|
2021
Q4 | $3.21M | Sell |
35,086
-1,348
| -4% | -$117K | 0.03% | 646 |
|
|
2021
Q3 | $2.78M | Sell |
36,434
-1,115
| -3% | -$92.7K | 0.03% | 685 |
|
|
2021
Q2 | $3.2M | Sell |
37,549
-1,111
| -3% | -$97.2K | 0.03% | 637 |
|
|
2021
Q1 | $3.17M | Sell |
38,660
-815
| -2% | -$61.7K | 0.03% | 642 |
|
|
2020
Q4 | $2.89M | Sell |
39,475
-1,505
| -4% | -$110K | 0.03% | 632 |
|
|
2020
Q3 | $3.03M | Sell |
40,980
-1,768
| -4% | -$118K | 0.03% | 535 |
|
|
2020
Q2 | $2.34M | Buy |
42,748
+784
| +2% | +$36.5K | 0.03% | 645 |
|
|
2020
Q1 | $1.55M | Sell |
41,964
-1,285
| -3% | -$67.9K | 0.02% | 707 |
|
|
2019
Q4 | $2.42M | Sell |
43,249
-1,288
| -3% | -$67.7K | 0.03% | 729 |
|
|
2019
Q3 | $2.08M | Sell |
44,537
-574
| -1% | -$26.1K | 0.02% | 771 |
|
|
2019
Q2 | $2.2M | Sell |
45,111
-95,124
| -68% | -$4.23M | 0.02% | 765 |
|
|
2019
Q1 | $5.71M | Buy |
140,235
+92,921
| +196% | +$3.57M | 0.02% | 823 |
|
|
2018
Q4 | $1.54M | Sell |
47,314
-1,158
| -2% | -$43.8K | 0.02% | 871 |
|
|
2018
Q3 | $2.17M | Sell |
48,472
-1,787
| -4% | -$84K | 0.02% | 826 |
|
|
2018
Q2 | $2.31M | Sell |
50,259
-3,242
| -6% | -$157K | 0.03% | 745 |
|
|
2018
Q1 | $2.69M | Sell |
53,501
-2,252
| -4% | -$126K | 0.03% | 658 |
|
|
2017
Q4 | $3.26M | Buy |
+55,753
| New | +$3.17M | 0.04% | 597 |
|
Other funds holding FBIN
GIM
FPA
FGP
MetLife Investment Management's FBIN Position: Q2 2026 in Review
MetLife Investment Management reduced its Fortune Brands Innovations (FBIN) stake by 2.9% in Q2 2026, selling an estimated $69.4K and leaving 57,380 shares worth $3.15M. The position accounts for 0.01% of the portfolio, ranked #888.
MetLife Investment Management first reported a position in FBIN in Q4 2017 and has held it in 35 quarters since. The position peaked at $5.87M in Q1 2024. 528 funds tracked by Wall St. Rank hold FBIN as of Q2 2026.
- MetLife Investment Management held 57,380 shares of Fortune Brands Innovations worth $3.15M as of Q2 2026.
- MetLife Investment Management sold 1,732 Fortune Brands Innovations shares in Q2 2026, an estimated $69.4K.
- Fortune Brands Innovations made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #888 holding.
- MetLife Investment Management first reported a position in Fortune Brands Innovations in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Fortune Brands Innovations position peaked at $5.87M in Q1 2024.
- 528 funds tracked by Wall St. Rank held Fortune Brands Innovations as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.